Hepatocellular carcinoma
RecruitingA Study of Atezolizumab and Bevacizumab Before and After Surgery in Patients with Liver Cancer at High Risk of Coming Back
A Study of Atezolizumab and Bevacizumab Before and After Surgery in Patients with Liver Cancer at High Risk of Coming Back
- Disease:Hepatocellular carcinoma
- Substances:AtezolizumabBevacizumab
Spain- Participants:18–64 years · 65+ years
- Substances:Atezolizumab
- Sponsor:Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques August Pi I Sunyer









